Related Experiment Videos
Malignant or accelerated hypertension in IgA nephropathy
Insights
Malignant hypertension is more common in adults with IgA nephropathy than previously thought. This condition can lead to rapid progression to end-stage renal failure, even with blood pressure management.
Area of Science:
- Nephrology
- Hypertension Research
- Renal Pathology
Background:
- Immunoglobulin A nephropathy (IgA nephropathy) is a common glomerular disease.
- Hypertension is a known complication and potential driver of IgA nephropathy progression.
- The association between IgA nephropathy and malignant hypertension in adults requires further elucidation.
Purpose of the Study:
- To determine the incidence of hypertension, particularly malignant hypertension, in adult patients diagnosed with IgA nephropathy.
- To investigate the clinical and histopathological characteristics of IgA nephropathy patients presenting with severe hypertension.
- To assess the renal outcomes in this patient cohort.
Main Methods:
- Retrospective analysis of 66 adult patients with biopsy-proven IgA nephropathy.
- Review of initial clinical presentation, including blood pressure and symptoms.
- Examination of renal biopsy histopathology, focusing on vascular changes.
- Tracking of patient outcomes, including progression to end-stage renal failure.
Main Results:
- 36% of patients were hypertensive at initial presentation.
- 15% of hypertensive patients had malignant or accelerated hypertension.
- Vascular findings included proliferative endarteritis, fibrinoid necrosis, arteriolosclerosis, and vascular hypertrophy.
- Six patients progressed to end-stage renal failure within 14 months, despite blood pressure control.
Conclusions:
- The incidence of malignant hypertension in adults with IgA nephropathy appears higher than previously reported.
- IgA nephropathy associated with malignant hypertension may lead to rapid renal failure.
- Further histopathologic studies are needed to confirm the true incidence and understand the pathogenesis of this association.
Abstract:
A retrospective analysis of 66 adult patients diagnosed as having IgA nephropathy by renal biopsy revealed that 24 (36%) were hypertensive when first seen. Of these hypertensive patients, 10 (15%) had malignant or accelerated hypertension. All patients but one were male and had no knowledge of their renal disease and sought medical advice for symptoms due to hypertension. Five patients had no history of gross hematuria. Histological vascular findings showed, in three proliferative endarteritis and fibrinoid necrosis, in five arteriolosclerosis and in two vascular hypertrophy. In spite of good blood pressure control, six patients reached terminal uremia within a maximum of 14 months. In summary, the incidence of malignant hypertension in adults with IgA nephropathy is higher than previously reported, and its true incidence can only be known if more histopathologic studies of patients with malignant hypertension are performed. Patients with this association reach end stage renal failure in a short period of time.